Table 3.

Statistical determinants of quality of life and of measurement discrepancy

Model Predictors	B	SE	Beta	p	95% CI	R square change	F change	Sig. F change
QoL discrepancy (patient-rated minus assessor-rated QoL z score)
Insight (BIS)	−0.04	0.04	−0.14	0.243	−0.12 to 0.03	0.204	15.63	<0.001
Negative symptoms (PANSS)	0.09	0.02	0.39	<0.001	0.04 to 0.13	0.097	8.34	0.005
Depression (CDSS)	−0.07	0.02	−0.39	<0.001	−0.11 to −0.03	0.090	8.75	0.004
Drug attitude (DAI)	−0.04	0.01	−0.35	0.003	−0.06 to −0.01	0.084	9.31	0.003
Patient-rated quality of life
Depression (CDSS)	−0.16	0.03	−0.68	<0.001	−0.22 to −0.10	0.339	30.26	<0.001
Insight (BIS)	−0.09	0.04	−0.22	0.029	−0.17 to −0.01	0.056	5.39	0.024
Non-neurological side-effects (ANNSERS)	0.04	0.02	0.28	0.025	0.01 to 0.08	0.040	4.08	0.048
Adherence (Kemp)	−0.24	0.11	−0.22	0.030	−0.45 to −0.02	0.046	4.93	0.030
Assessor-rated quality of life
Negative symptoms (PANSS)	−2.00	0.33	−0.57	<0.001	−2.65 to −1.35	0.427	48.48	<0.001
Drug attitude (DAI)	0.46	0.15	0.29	0.003	0.17 to 0.75	0.077	9.89	0.003